Source of Support: None, Conflict of Interest: None
Thirty patients of atopic dermatitis were tested with intradermal pilocarpine and examined for cutaneous vascular response at the site. Both the involved and normal- appearing skin sites were injected. Patients with non-atopic dermatitis were used as controls. Eighty percent of the patients showed either reduced erythema or nil erythema around the test site.